Circulating fetuin-A levels are thereby found to be strongly increased in the course of obesity, metabolic syndrome, and type 2 diabetes, and are correlated with hepatic steatosis and CVD in humans [66]. This evidence concerns the gene AHSG and obesity due to melanocortin 4 receptor deficiency.